Sablich Kim 4
4 · Jazz Pharmaceuticals plc · Filed Mar 7, 2023
Insider Transaction Report
Form 4
Sablich Kim
EVP, GM of U.S.
Transactions
- Award
Ordinary Shares
[F1]2023-03-03+10,429→ 35,183 total - Tax Payment
Ordinary Shares
[F2]2023-03-05$142.78/sh−1,610$229,876→ 33,573 total
Footnotes (2)
- [F1]These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2023, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.
- [F2]Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
Signature
By: /s/Adam Guttmann, as attorney in fact For: Kimberly Sablich|2023-03-07